Biotechnology company developing cancer therapies that target cancer stem cells
Biotechnology company developing cancer therapies that target cancer stem cells. Its proprietary platforms identify cancer stem cells and novel targets, and support the engineering and GMP manufacturing of antibodies and antibody-drug conjugates (ADCs). It also developed companion diagnostic tests to identify patients likely to benefit from its drugs. Its investigational therapies have been studied in clinical trials for several solid tumors, including small cell lung cancer, triple-negative and